Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alpha 2-adrenoceptor participates in anti-hyperalgesia by regulating metabolic demand. | Front Pharmacol | 2024 | 38584597 | PubTator, text mining | PubMed |
| Identification of a novel inflammatory-related gene signature to evaluate the prognosis of gastric cancer patients. | World J Gastrointest Oncol | 2024 | 38577477 | PubTator, text mining | PubMed |
| circFTO from M2 macrophage-derived small extracellular vesicles (sEV) enhances NSCLC malignancy by regulation miR-148a-3pPDK4 axis. | Cancer Immunol Immunother | 2024 | 38554157 | PubTator, text mining | PubMed |
| MAPK14 as a key gene for regulating inflammatory response and macrophage M1 polarization induced by ferroptotic keratinocyte in psoriasis. | Inflammation | 2024 | 38441793 | PubTator, text mining | PubMed |
| Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics. | PeerJ | 2024 | 38436027 | PubTator, text mining | PubMed |
| Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation. | Inflammation | 2024 | 38401019 | PubTator, text mining | PubMed |
| Pan-cancer proteogenomics characterization of tumor immunity. | Cell | 2024 | 38359819 | PubTator, text mining | PubMed |
| PDK4 inhibits osteoarthritis progression by activating the PPAR pathway. | J Orthop Surg Res | 2024 | 38308345 | PubTator, text mining | PubMed |
| Metabolic regulation of the hallmarks of stem cell biology. | Cell Stem Cell | 2024 | 38306993 | PubTator, text mining | PubMed |
| Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis. | JHEP Rep | 2024 | 38304234 | PubTator, text mining | PubMed |
| Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors. | Heliyon | 2024 | 38293446 | PubTator, text mining | PubMed |
| Mitochondrial-to-nuclear communications through multiple routes regulate cardiomyocyte proliferation. | Cell Regen | 2024 | 38291287 | PubTator, text mining | PubMed |
| A novel genetic model provides a unique perspective on the relationship between postexercise glycogen concentration and increases in the abundance of key metabolic proteins after acute exercise. | PLoS One | 2024 | 38289946 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma. | J Bone Oncol | 2024 | 38288377 | PubTator, text mining | PubMed |
| Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. | Noncoding RNA Res | 2024 | 38282696 | PubTator, text mining | PubMed |
| Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions. | Genome Med | 2024 | 38281962 | PubTator, text mining | PubMed |
| Palmitoylation of PKCδ by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease. | Theranostics | 2024 | 38250049 | PubTator, text mining | PubMed |
| Breast Cancer: Mitochondria-Centered Metabolic Alterations in Tumor and Associated Adipose Tissue. | Cells | 2024 | 38247846 | PubTator, text mining | PubMed |
| Resistance and aerobic training increases genome-wide DNA methylation in women with polycystic ovary syndrome. | Epigenetics | 2024 | 38245873 | PubTator, text mining | PubMed |
| The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. | Cancer Cell Int | 2024 | 38238756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=13